用eltrombopag治疗耐火/复发的钻石-布莱克芬贫血的治疗方法
Brynn B Duncan1, Jennifer L Lotter2, Jeanine Superata2
1Translational Stem Cell Biology Branch, NHLBI, Bethesda, Maryland, USA.
British journal of haematology
|March 11, 2024
概括
埃尔特罗姆波巴格在钻石黑人贫血 (DBA) 患者中显示出有利的安全性,在一些患者中改善了红细胞 (RBC) 产生. 然而,由于血栓细胞形成的剂量调整,在大多数人群中限制了它的有效性.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 钻石-布莱克芬贫血 (DBA) 是一种罕见的遗传性骨髓衰竭综合征.
- DBA涉及核糖体缺陷,导致全球蛋白生产减少和铁过载.
- 埃尔特罗姆波帕格 (Eltrombopag) 是一种血栓形成素受体激活剂,是一种铁化剂,在RPS19突变的DBA患者中取得了先前的成功.
研究的目的:
- 评估eltrombopag在改善DBA患者的红色球蛋白产生的安全性和有效性.
- 评估eltrombopag对红细胞 (RBC) 生产和输血需求的影响.
主要方法:
- 进行了一项单中心,单臂试点研究 (NCT04269889).
- 15名依赖输血的DBA患者每天接受固定剂量的ELTROMBOPAG,持续6个月.
- 监测了安全性和红状腺反应.
主要成果:
- 一名患者实现了持续的血红蛋白改善和输血频率>50%的减少.
- 41%的患者 (7/15) 由于无症状的血栓细胞形成,需要减少剂量或停止治疗.
- 尽管总体响应率较低,但Eltrombopag的安全性表现良好.
结论:
- 埃尔特伦博巴格可以改善一些DBA患者的红细胞形成,但其疗效受到由于血栓细胞瘤的剂量限制而受到限制.
- 血栓细胞瘤可以防止足够的铁化以改善大多数DBA患者的贫血.
- 未来的研究应该探索替代治疗方法,可能涉及合成抑制剂,而不会对其他细胞系产生影响.
更多相关视频
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
29.3K
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
19.5K
相关概念视频
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
165
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
165
01:22Bone Marrow Sampling and Transplants
330
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
330
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K